Although Shiga toxin 2 (Stx2) is more commonly associated with HUS than Stx1 [1], [2], immunoglobulin-depleted human serum possesses an innate ability to neutralize the cytotoxic activity of Stx2 [3]. Here, STX2 is linked to hemolytic-uremic syndrome.